000 | 01261 a2200361 4500 | ||
---|---|---|---|
005 | 20250516032451.0 | ||
264 | 0 | _c20110512 | |
008 | 201105s 0 0 eng d | ||
022 | _a0029-2559 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCates, Willard | |
245 | 0 | 0 |
_aThe North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action. _h[electronic resource] |
260 |
_bNorth Carolina medical journal _c |
||
300 |
_a490-1 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xprevention & control |
650 | 0 | 4 |
_aAdenine _xadministration & dosage |
650 | 0 | 4 | _aAdministration, Intravaginal |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 |
_aHIV Infections _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterinstitutional Relations |
650 | 0 | 4 | _aNorth Carolina |
650 | 0 | 4 |
_aOrganophosphonates _xadministration & dosage |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aSouth Africa |
650 | 0 | 4 | _aTenofovir |
650 | 0 | 4 | _aUniversities |
700 | 1 | _aKashuba, Angela D M | |
773 | 0 |
_tNorth Carolina medical journal _gvol. 71 _gno. 5 _gp. 490-1 |
|
999 |
_c20740808 _d20740808 |